Molecular insights into the microtubules depolymerizing activity of the IL-8 receptor B antagonist SB225002

CONCLUSIONS: Findings of the present study warrants further development of SB225002 as a lead compound that uniquely targets microtubules dynamics and IL-8 signaling.PMID:35647855 | DOI:10.26355/eurrev_202205_28869

Source: European Review for Medical and Pharmacological Sciences - June 1, 2022 Category: Drugs & Pharmacology Authors: A E Goda T Sakai Source Type: research